Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J
INSERM U-159, Centre Paul Broca, Paris, France.
Endocrinology. 1998 May;139(5):2272-7. doi: 10.1210/endo.139.5.5990.
In the present study, we tested whether 17beta-estradiol (E2)-induced PRL sensitivity to somatostatin-14 (SRIF) involves selective up-regulation of discrete somatostatin receptor subtypes (ssts) in primary cultures of female rat pituitary cells. The efficacy of the endogenous peptide SRIF to inhibit GH and PRL secretion and cAMP accumulation was compared with those of octreotide (OCT), BIM-23052, BIM-23056, and BIM-23268, which have been reported to be relatively selective for rat sst2, sst3, and sst5. Experiments were performed in steroid-depleted media supplemented or not with 1 nM E2 for 96 h. SRIF, OCT, and BIM-23052 inhibited cAMP accumulation and GH release independently of E2. In contrast, all three agonists affected PRL release in E2-treated cultures only. Inhibition of cAMP accumulation by SRIF, OCT, and BIM-23052 was enhanced by exposure of cells to E2. The rank of potency of the agonists, OCT = SRIF > BIM-23052, was similar for GH and PRL inhibition. BIM-23268 was a weak agonist on GH, but not on PRL, secretion. BIM-23056 had no effect on the release of either hormone, but slightly inhibited cAMP formation in E2-treated cells. To verify whether SRIF receptor gene expression correlated with these observations, messenger RNA (mRNA) transcripts corresponding to the five ssts were measured by quantitative RT-PCR in the presence or absence of E2. Control cells expressed predominantly sst2 and sst3 transcripts; sst1 mRNA was present in moderate amounts, whereas sst4 and sst5 were only weakly expressed. E2 had a differential effect on distinct ssts; it increased mRNA concentrations corresponding to sst2 and sst3, and decreased that of sst1. These results indicate that sst2 and sst3 receptors are the major somatostatin receptors expressed in the female rat pituitary, and that both of them are positively regulated by estradiol. However, the capacity of lactotropes to respond to SRIF after exposure to E2 seems to depend more upon E2-induced up-regulation of the sst2 than of the sst3 receptor subtype.
在本研究中,我们测试了17β-雌二醇(E2)诱导的催乳素(PRL)对生长抑素-14(SRIF)的敏感性是否涉及雌性大鼠垂体细胞原代培养物中离散生长抑素受体亚型(ssts)的选择性上调。将内源性肽SRIF抑制生长激素(GH)和PRL分泌以及环磷酸腺苷(cAMP)积累的效力与奥曲肽(OCT)、BIM-23052、BIM-23056和BIM-23268的效力进行了比较,据报道这些物质对大鼠sst2、sst3和sst5具有相对选择性。实验在补充或不补充1 nM E2的类固醇缺乏培养基中进行96小时。SRIF、OCT和BIM-23052抑制cAMP积累和GH释放,与E2无关。相反,所有三种激动剂仅在E2处理的培养物中影响PRL释放。细胞暴露于E2后,SRIF、OCT和BIM-23052对cAMP积累的抑制作用增强。激动剂的效力顺序为OCT = SRIF > BIM-23052,在抑制GH和PRL方面相似。BIM-23268对GH分泌是弱激动剂,但对PRL分泌不是。BIM-23056对两种激素的释放均无影响,但在E2处理的细胞中略微抑制cAMP形成。为了验证SRIF受体基因表达是否与这些观察结果相关,在有或没有E2的情况下,通过定量逆转录聚合酶链反应(RT-PCR)测量了对应于五种ssts的信使核糖核酸(mRNA)转录本。对照细胞主要表达sst2和sst3转录本;sst1 mRNA含量适中,而sst4和sst5仅微弱表达。E2对不同的ssts有不同的影响;它增加了对应于sst2和sst3的mRNA浓度,并降低了sst1的mRNA浓度。这些结果表明,sst2和sst3受体是雌性大鼠垂体中表达的主要生长抑素受体,并且它们两者都受到雌二醇的正向调节。然而,催乳细胞在暴露于E2后对SRIF作出反应的能力似乎更多地取决于E2诱导的sst2受体亚型上调,而不是sst3受体亚型上调。